The Ministry of Trade, Industry and Energy is pushing to designate key technologies used in the development of biopharmaceuticals as "national high-tech strategic technologies." If bio-core technology is designated as a state-of-the-art strategic technology, various benefits will follow. They include support for the creation of specialized complexes, training professionals through the establishment of specialized graduate schools, and tax credits. In particular, it is known that tax credits can receive up to 40% of R&D costs and up to 16% of facility investment.

In November last year, the Ministry of Industry selected 15 core technologies in semiconductor, display, and secondary battery fields as state-